Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on May 5, 2026 by admin

Group PACBT for Depression

Conditions: Depression – Major Depressive Disorder; Psilocybin; Cognitive Behavioral Therapy

Interventions: Drug: Psilocybin (drug); Behavioral: Group Cognitive Behavioral Therapy

Sponsors: University of California, Los Angeles

Not yet recruiting
CategoriesClinicalTrials.gov TagsAlternative therapies, CBT, Depression, Mood and emotional regulation, News Approved, United States

Post navigation

Previous PostPrevious Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
Next PostNext KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.